FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005422079> ?p ?o ?g. }

• W2005422079 endingPage "e67" @default.
• W2005422079 startingPage "e67" @default.
• W2005422079 abstract "Somatic genetic CDKN2A, TP53, and DNA content abnormalities are common in many human cancers and their precursors, including esophageal adenocarcinoma (EA) and Barrett's esophagus (BE), conditions for which aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) have been proposed as possible chemopreventive agents; however, little is known about the ability of a biomarker panel to predict progression to cancer nor how NSAID use may modulate progression. We aimed to evaluate somatic genetic abnormalities with NSAIDs as predictors of EA in a prospective cohort study of patients with BE.Esophageal biopsies from 243 patients with BE were evaluated at baseline for TP53 and CDKN2A (p16) alterations, tetraploidy, and aneuploidy using sequencing; loss of heterozygosity (LOH); methylation-specific PCR; and flow cytometry. At 10 y, all abnormalities, except CDKN2A mutation and methylation, contributed to EA risk significantly by univariate analysis, ranging from 17p LOH (relative risk [RR] = 10.6; 95% confidence interval [CI] 5.2-21.3, p < 0.001) to 9p LOH (RR = 2.6; 95% CI 1.1-6.0, p = 0.03). A panel of abnormalities including 17p LOH, DNA content tetraploidy and aneuploidy, and 9p LOH was the best predictor of EA (RR = 38.7; 95% CI 10.8-138.5, p < 0.001). Patients with no baseline abnormality had a 12% 10-y cumulative EA incidence, whereas patients with 17p LOH, DNA content abnormalities, and 9p LOH had at least a 79.1% 10-y EA incidence. In patients with zero, one, two, or three baseline panel abnormalities, there was a significant trend toward EA risk reduction among NSAID users compared to nonusers (p = 0.01). The strongest protective effect was seen in participants with multiple genetic abnormalities, with NSAID nonusers having an observed 10-y EA risk of 79%, compared to 30% for NSAID users (p < 0.001).A combination of 17p LOH, 9p LOH, and DNA content abnormalities provided better EA risk prediction than any single TP53, CDKN2A, or DNA content lesion alone. NSAIDs are associated with reduced EA risk, especially in patients with multiple high-risk molecular abnormalities." @default.
• W2005422079 created "2016-06-24" @default.
• W2005422079 creator A5009066636 @default.
• W2005422079 creator A5011306393 @default.
• W2005422079 creator A5025406097 @default.
• W2005422079 creator A5029347595 @default.
• W2005422079 creator A5046153450 @default.
• W2005422079 creator A5057244007 @default.
• W2005422079 creator A5059964281 @default.
• W2005422079 creator A5061079739 @default.
• W2005422079 creator A5062132898 @default.
• W2005422079 creator A5083729859 @default.
• W2005422079 date "2007-02-27" @default.
• W2005422079 modified "2023-10-07" @default.
• W2005422079 title "NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma" @default.
• W2005422079 cites W1486933127 @default.
• W2005422079 cites W1518353833 @default.
• W2005422079 cites W1529605718 @default.
• W2005422079 cites W1551210608 @default.
• W2005422079 cites W1562156536 @default.
• W2005422079 cites W1573413333 @default.
• W2005422079 cites W1581870304 @default.
• W2005422079 cites W1632319133 @default.
• W2005422079 cites W1644411965 @default.
• W2005422079 cites W1824572340 @default.
• W2005422079 cites W1848388241 @default.
• W2005422079 cites W1923803423 @default.
• W2005422079 cites W1958574868 @default.
• W2005422079 cites W1963767908 @default.
• W2005422079 cites W1964129698 @default.
• W2005422079 cites W1964653907 @default.
• W2005422079 cites W1966971933 @default.
• W2005422079 cites W1968038516 @default.
• W2005422079 cites W1970171132 @default.
• W2005422079 cites W1973568247 @default.
• W2005422079 cites W1975076018 @default.
• W2005422079 cites W1975560535 @default.
• W2005422079 cites W1975875177 @default.
• W2005422079 cites W1978108315 @default.
• W2005422079 cites W1982850112 @default.
• W2005422079 cites W1984770572 @default.
• W2005422079 cites W1985381981 @default.
• W2005422079 cites W1985757925 @default.
• W2005422079 cites W1992965559 @default.
• W2005422079 cites W1993228606 @default.
• W2005422079 cites W1997850959 @default.
• W2005422079 cites W2001258296 @default.
• W2005422079 cites W2001928302 @default.
• W2005422079 cites W2003579067 @default.
• W2005422079 cites W2004315708 @default.
• W2005422079 cites W2004730446 @default.
• W2005422079 cites W2006645102 @default.
• W2005422079 cites W2012876773 @default.
• W2005422079 cites W2026387101 @default.
• W2005422079 cites W2028667429 @default.
• W2005422079 cites W2043997767 @default.
• W2005422079 cites W2044368607 @default.
• W2005422079 cites W2045127064 @default.
• W2005422079 cites W2048635345 @default.
• W2005422079 cites W2050808833 @default.
• W2005422079 cites W2051700726 @default.
• W2005422079 cites W2052636252 @default.
• W2005422079 cites W2052816071 @default.
• W2005422079 cites W2055951936 @default.
• W2005422079 cites W2059997545 @default.
• W2005422079 cites W2060757790 @default.
• W2005422079 cites W2062011416 @default.
• W2005422079 cites W2069358051 @default.
• W2005422079 cites W2070035493 @default.
• W2005422079 cites W2073172834 @default.
• W2005422079 cites W2073576377 @default.
• W2005422079 cites W2075255580 @default.
• W2005422079 cites W2076984763 @default.
• W2005422079 cites W2077470100 @default.
• W2005422079 cites W2078604197 @default.
• W2005422079 cites W2080812486 @default.
• W2005422079 cites W2084819007 @default.
• W2005422079 cites W2085040479 @default.
• W2005422079 cites W2085130683 @default.
• W2005422079 cites W2086698289 @default.
• W2005422079 cites W2087025655 @default.
• W2005422079 cites W2088485119 @default.
• W2005422079 cites W2090213224 @default.
• W2005422079 cites W2092654917 @default.
• W2005422079 cites W2097903769 @default.
• W2005422079 cites W2100894466 @default.
• W2005422079 cites W2101603900 @default.
• W2005422079 cites W2101947806 @default.
• W2005422079 cites W2105224356 @default.
• W2005422079 cites W2106088192 @default.
• W2005422079 cites W2107145416 @default.
• W2005422079 cites W2107700622 @default.
• W2005422079 cites W2111110115 @default.
• W2005422079 cites W2116177188 @default.
• W2005422079 cites W2122543246 @default.
• W2005422079 cites W2124414749 @default.
• W2005422079 cites W2126346206 @default.
• W2005422079 cites W2127099403 @default.

• next